In February, innovation company Speximo completed a rights issue to raise SEK 5 million. Sparbanksstiftelsen Skåne’s Riskkapitalstiftelse (Venture Capital Foundation) is now a new partner.
The Swedish company has a unique, green method for stabilization of skin creams and encapsulation of active ingredients.
In 2016 the company increased the number of market contacts manyfold. Companies all over Europe are evaluating the ingredient and the technology for a potential licensing deal. Speximo also carries out customer projects in which the technology is developed to meet specific needs.
In addition, Vinnova granted project funding to Speximo as part of the Innovative Startups program. The “Innovative platform for drug formulation” project will be carried out in collaboration with Follicum AB, which has a substance that inhibits unwanted hair growth.
“We’ve received an extremely positive response from the market, and the fact that the rights issue was oversubscribed shows that our owners, customers and partners all believe in us and the technology,” says Malin Sjöö, CEO and one of the founders of Speximo.
“Our companies have historically been successful in attracting venture capital. These high-quality projects possess great commercial potential,” says Ebba Fåhreaus, CEO at SmiLe Incubator.
Speximo has a patented technology for the formulation of skin creams based on a natural ingredient: starch from quinoa. Speximo’s product has a number of unique advantages for stabilization of skin products and produces a pleasant feeling on the skin. The method can also be used for encapsulation of active ingredients of pharmaceuticals, cosmetics and foods. The Company was founded in 2012 as a spin-off from Lund University. Previous partners in addition to the founders include LU Holding, Almi Invest and business angels.
Speximo is an incubator company at SmiLe Incubator in Lund, Sweden.
For more information, please contact